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Background: Signalling by the T cell antigen receptor (TCR) results in the activation of T lymphocytes. Nck1 and
Nck2 are two highly related adaptor proteins downstream of the TCR that each contains three SH3 and one SH2
domains. Their individual functions and the roles of their SH3 domains in human T cells remain mostly unknown.
Results: Using specific shRNA we down-regulated the expression of Nck1 or Nck2 to approximately 10% each in
Jurkat T cells. We found that down-regulation of Nck1 impaired TCR-induced phosphorylation of the kinases Erk
and MEK, activation of the AP-1 and NFAT transcription factors and subsequently, IL-2 and CD69 expression. In sharp
contrast, down-regulation of Nck2 hardly impacts these activation read-outs. Thus, in contrast to Nck2, Nck1 is a
positive regulator for TCR-induced stimulation of the Erk pathway. Mutation of the third SH3 domain of Nck1
showed that this domain was required for this activity. Further, TCR-induced NFAT activity was reduced in both
Nck1 and Nck2 knock-down cells, showing that both isoforms are involved in NFAT activation. Lastly, we show that
neither Nck isoform is upstream of p38 phosphorylation or Ca2+influx.
Conclusions: In conclusion, Nck1 and Nck2 have non-redundant roles in human T cell activation in contrast to
murine T cells.
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T cells play an important role in adaptive immunity. They
express a structurally unique receptor called the T cell
antigen receptor (TCR). The TCR is composed of the vari-
able antigen-binding TCRαβ heterodimer noncovalently
associated with the non-variable CD3εγ, CD3εδ and ζζ
signal transduction subunits [1]. Binding of the TCR
to peptide-loaded major histocompatibility complexes
(pMHCs) presented on the surface of antigen presenting
cells (APCs) initiates the formation of intracellular protein
signalling complexes [2]. The formation of these com-
plexes is required for T cell activation and is driven by
adaptor proteins in order to activate downstream path-
ways, such as the Ras-mitogen-activated protein kinase
(MAPK), protein kinase C (PKC) and Ca2+-mediated* Correspondence: sutatipp@nu.ac.th
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article, unless otherwise stated.signalling pathways. Stimulation of these pathways results
in the activation of the transcription factors activator
protein-1 (AP-1), nuclear factor kappa-light-chain-enhan-
cer of activated B cells (NF-κB) and nuclear factor of acti-
vated T cells (NFAT), respectively [3]. The cooperative
activity of these transcription factors is required for the
regulation of interleukin-2 (IL-2) production [4].
Two highly conserved members of the cytosolic adaptor
protein Nck (non-catalytic region of tyrosine kinase) are
found in humans: Nck1/Nckα and Nck2/Nckβ (also
known as Grb4) [5,6]. These two proteins have a 68%
similarity when the amino acid sequences are compared
[7]. Nck consists of three consecutive Src homology 3
(SH3) domains at N-terminus followed by a SH2 domain
at the C-terminus [5]. The SH2 domain of Nck binds to
phosphotyrosine-containing proteins, and the SH3 do-
mains bind to proline-rich sequences (PRS) within target
proteins [7,8]. In T cells, the SH2 domain of Nck mediates
the interaction with phosphorylated SLP-76 (SH2
domain-containing leukocyte protein of 76 kDa), while
each of the SH3 domains interacts with distinct targettral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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PRS in the cytoplasmic tail of CD3ε exposed upon
antigen-induced conformational changes within the TCR
complex. This interaction is required for IL-2 production
and synapse formation [9]. The SH3.2 domain of Nck in-
teracts with the kinase Pak1, which is essential for regula-
tion of the reorganization of actin cytoskeleton [7,10,11]
and for activation of NFAT [12]. The SH3.3 domain of
Nck binds to WASp to control actin polymerization [13]
and with the Son of Sevenless (SOS) [10,14]. The guanine
nucleotide exchange factor SOS is required for activation
of the Ras-Raf-MEK-Erk pathway [15].
Double Nck1 and Nck2-knockout mice die in early
embryonic stage, whereas singly Nck1 or Nck2 deleted
mice do not possess any phenotype, suggesting a re-
dundant function of these two molecules in mice [16].
Recently, we have downregulated Nck1 expression in
human Jurkat T cells and primary human CD4+ T cells
using siRNA, showing that Nck1 expression is required
for TCR-induced phosphorylation of Erk1/2, IL-2 pro-
duction and CD69 expression [17]. These results suggest
species specific differences in the role of Nck1 and
Nck2. The aim of the present study was to compare the
roles of Nck1 and Nck2 in TCR-mediated T cell re-
sponses in the human system. Our results demonstrate
that Nck1 and Nck2 have non redundant roles in human
T cell activation. Thus, Nck1 plays a more dominant role
in TCR-mediated T cell activation in the human system
than Nck2.
Results
Generation of Nck1- and Nck2-knockdown Jurkat T cells
In this present study, the functions of Nck1 and Nck2
in activation of Jurkat T-cell leukemic line E6-1 were
compared. To knockdown either Nck1 or Nck2, Jurkat
T cells were transfected with a plasmid encoding either
Nck1- or Nck2-specific short hairpin RNA (shRNA) or
an empty control plasmid. For generating the stable
Nck1- or Nck2-knockdown Jurkat T cell lines, the trans-
fected cells were selected in medium containing puro-
mycin. The resulting bulk population was subcloned by
limiting dilution. Individual clones were screened by
analyzing Nck1, Nck2 and TCR expression. The selected
clones had about 90% downregulation of endogenous
Nck1 and Nck2 (Figure 1A) and a similar level of CD3
expression as control cells (Figure 1B). Here, we chose
one clone each that will be named shNck1 and shNck2.
Nck1 is required for TCR-mediated T cell activation
Next, we tested whether the downmodulation of Nck1 or
Nck2 had an impact on TCR-induced expression of the
early activation marker CD69. Cells were stimulated with
anti-CD3ε antibodies (OKT3) or with TCR-independent
stimuli phytohemagglutinin (PHA)/phorbol myristateacetate (PMA). Nck1-knockdown Jurkat T cells exhi-
bited decreased CD69 expression in response to CD3
stimulation (Figure 1C). In contrast, silencing of Nck2
in Jurkat T cells had no effect on CD69 expression. As a
control, a similar level of CD69 expression was observed
in Nck1- and Nck2-knockdown cells in response to
PHA plus PMA (Figure 1D).
Another important marker for indicating T cell activa-
tion is IL-2. Therefore, the production of IL-2 was inves-
tigated in Nck1- and Nck2-knockdown cells. Cells were
stimulated with anti-CD3ε antibodies (OKT3) or TCR-
independent stimuli (PHA/PMA). Consistent with our
previous report [17], gene-silencing of Nck1 resulted in a
significant decrease in IL-2 production (Figure 1E). In
contrast, IL-2 production was normal in Jurkat cells trans-
fected with shRNA specific for Nck2 . As expected, no
difference in IL-2 production was observed between
Nck1- and Nck2-knockdown cells upon stimulation with
PHA/PMA (Figure 1F). Taken together, these results
showed that in contrast to Nck2, Nck1 was required for
TCR-mediated T cell activation in Jurkat T cells.
Nck1 regulated the activation of Ras-MAPK signalling
pathway
Following engagement of TCR, the small GTPases Ras
and Rac are activated, and subsequently activate the
MAPK signalling cascade. There are three groups of
enzymes in the MAPK signalling cascade that are sequen-
tially activated: MAP kinase kinase kinase (MKKK, MEKK
or MAP3K), MAP kinase kinase (MKK, MEK, or MAP2K)
and MAP kinase (MAPK). Three MAPKs are expressed in
T cells: Erk1/2, JNK and p38 [3].
Our previous study has shown that reduced Nck1 ex-
pression is associated with impaired Erk1/2 phospho-
rylation [17]. Nck1 and Nck2 may be differently required
for MAPK signalling cascade in Jurkat cells. To test this
notion, the activation of two members of MAPK pathway,
Erk1/2 and p38 was investigated using Jurkat T cells with
silenced expression of Nck1 or Nck2. Reduced Erk1/2
phosphorylation was found in Nck1-, but not in Nck2-
knockdown cells (Figure 2A). To confirm that Nck1 is
required for activation of the MAPK pathway via the
Ras-Raf-MEK-Erk cascade, we investigated the activation
of the upstream enzyme essential for Erk1/2 phosphory-
lation: MEK1/2. As expected, cells treated with shRNA
specific for Nck1 exhibited impaired MEK1/2 phosphory-
lation (Figure 2B). Interestingly, in contrast to Erk1/2 and
MEK1/2 phosphorylation, knockdown of Nck1 or Nck2 in
Jurkat T cells had no discernible effects on p38 phospho-
rylation (Figure 2C). Because all these results were ob-
tained from single clones of Nck1- and Nck2-knockdown
cells, we confirmed these findings using polyclonal Nck1-
and Nck2-knockdown lines to exclude clonal variations.





Figure 1 Nck1 is required for TCR-mediated CD69 expression and interleukin (IL)-2 production. A) Jurkat T cells were transfected with a
control vector, Nck1- or Nck2-specific shRNA expression vector. Transfected cells were selected in medium containing 4 μg/ml puromycin for
4–7 days before cloning by limiting dilution. Cell extracts were subjected to Western blot analysis with anti-Nck1, −Nck2 monoclonal antibody
(mAb) and anti-GAPDH mAb. B) The expression levels of surface CD3 molecules of the cloned cells from each population were measured by flow
cytometry. C-D). Nck1-knockdown (shNck1), Nck2-knockdown (shNck2) and control cells (mock) were stimulated with 1 μg/ml anti-CD3 antibody-
coated plates (C) or 6 μg/ml PHA plus 1 ng/ml PMA (D) for 24 h. Each cell population was stained with anti-CD69 conjugated phycoerythrin (PE)
and isotype control antibody and then analysed by flow cytometry. The expression of CD69 was displayed in both histogram (left) and bar graph
(right). For bar graph, the fraction of cells expressing CD69 in each population was normalized to its isotype control. E-F) Cells were stimulated as
in C-D. The supernatants from CD3 (E) and PHA/PMA stimulation (F) were measured for IL-2 production by ELISA. Results from CD69 expression
and IL-2 production are shown as mean ± SD from triplicate samples and were compared among the groups by using the two-tailed unpaired
t test. The p-value less than 0.05 were considered for statistical significance. Data are representative of three independent experiments.
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Figure 2 Nck1, but not Nck2, is essential for activation of Erk1/2 and MEK1/2 proteins. Cells from each monoclonal group were untreated
or treated with soluble CD3 antibody (1 μg/ml) at various time points. Cell lysates were subjected to immunoblot with anti-phospho-Erk1/2
antibody (A). Below, the quantified signal intensity of the pErk1/2 was normalized to its total kinase and this value was relative to that in the
unstimulated control cells (Mock), set as 1 (black dashed line) and plotted in bar graph. B) Immunoblot analysis of phospho-MEK1/2 from the
lysates of cells that were stimulated as in A. Below, signal intensity was quantified and presented as a ratio of p-MEK1/2 to actin relative to that in
unstimulated control cells (Mock), set as 1 (black dashed line). C) Immunoblot analysis of phospho-p38. Below, signal intensity was quantified and
presented as described in A. D). Polyclonal cells from Mock, Nck1- and Nck2-knockdown cells were stimulated as in A. Below, signal intensity was
quantified and presented as described in A. E) Both Nck1 and Nck2 genes were co-silenced in Jurkat T cells. Nck expression levels were analysed
by immunoblotting using indicated antibodies. F) The expression levels of surface CD3 molecules on double knockdown Nck1/2 were measured
by flow cytometry. G) Cells from each monoclonal group, Nck1-, Nck2- and Nck1/2-knockdown cells were treated as in A for 0, 3 and 30 min.
Lysates were subjected to immunoblot with anti-phospho-Erk1/2 antibody. Below, signal intensity was quantified and presented as described in
A. Data are representative of at least two independent experiments.
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observed in polyclonal Nck1-knockdown, but not in poly-
clonal Nck2-knockdown lines (Figure 2D). These data
show that while Nck1 is required for efficient MEK-Erk
activation, Nck2 is dispensable.
To study the possibility of synergistic function of the
two Nck isoforms, co-silencing of Nck1 and Nck2 in
Jurkat T cells was performed. Jurkat T cells were co-
transfected with the Nck1- and the Nck2-specific shRNA
expression plasmids, which resulted in downregulation of
the expression of both Nck isoforms (Figure 2E). The
expression of the TCR on T cell surface of double knock-
down cells was similar to each single knockdown popula-
tion (Figure 2F). Simultaneous knockdown of both Nck1
and Nck2 in Jurkat T cells led to further reduction of
TCR-induced Erk1/2 phosphorylation than that seen
in Nck1-knockdown cells (Figure 2G). Thus, these data
might suggest an additive functions of Nck1 and Nck2 in
TCR-induced Erk1/2 activation.
To confirm that the results observed in human leu-
kemic T cell lines were also reproduced in primary cells,
human PBMCs were used to study the function of Nck1
and Nck2 in T cell activation. PBMCs were transiently
transfected with siRNA specific to either Nck1 or Nck2
or both Nck1 and Nck2. In comparison with cells
treated with control siRNA, cells treated with specific
siRNA showed only reduction in the expression for the
corresponding Nck isoform (Figure 3A) without affec-
ting the surface TCR levels (Figure 3B). Consistent with
Jurkat T cells, PBMCs treated with siRNA specific to
Nck1, but not Nck2, exhibited an impairment of TCR-
induced surface expression of CD69 (Figure 3C). In-
terestingly, inhibition of both Nck1 and Nck2 in PBMCs
led to an additive defect in CD69 expression following
CD3 stimulation. However, silencing of either Nck1 or
Nck2 and co-silencing of Nck1 and Nck2 simultaneously
had no effect on CD69 expression in response to TCR-
independent stimulation using PHA/PMA (Figure 3D).
These data confirmed the importance of Nck1 in TCR-
mediated T cell activation also in human primary cells
and point out a possible collaboration between Nck1and Nck2 to optimally up-regulate CD69 upon TCR-
activation.
Nck1 and Nck2 are not required for Ca2+ mobilization
In addition to MAPK signalling pathway, the involvement
of Nck1 and Nck2 in other pathways was assessed. Nck
has been suggested to be implicated in Ca2+ signalling in
the mouse system, since Nck-knockout mice showed im-
pairment of Ca2+ mobilization in response to TCR stimu-
lation [18]. Thus, whether human Nck1 and Nck2 are
involved in Ca2+ immobilization was investigated. In con-
trast to the mouse system, knockdown of Nck1 or Nck2
in Jurkat T cells did not perturb Ca2+ influx following
TCR stimulation at optimal anti-CD3 antibody concentra-
tion (Figure 4A). Moreover, no differences in Ca2+ influx
were observed between Nck1- or Nck2 knockdown cells
following stimulation at limiting concentration of the
stimulating antibody (data not shown). Thus, in Jurkat
T cells, Ca2+ mobilization is independent of Nck1 or Nck2
expression upon TCR triggering.
Next, we investigated IκBα phosphorylation upon TCR
triggering. IκBα is phosphorylated downstream of pro-
tein kinase C (PKC). It was found that downregulation
of neither Nck1 nor Nck2 altered IκBα phosphorylation
in response to TCR stimulation (Figure 4B). Altogether,
these data indicated that Nck1 or Nck2 are dispen-
sable for Ca2+ mobilization and IκBα phosphorylation in
Jurkat T cells.
IL-2 gene transcription requires NFAT-AP-1 complexes
binding to the IL-2 promoter region. Due to the impair-
ment of IL-2 secretion in Nck1-knockdown Jurkat T cells,
the activation of transcription factors AP-1 and NFAT was
investigated. Nck1- and Nck2-knockdown Jurkat T cells
were transfected with luciferase reporter plasmids con-
taining either an AP-1 binding site or three tandem re-
peats of the distal NFAT biding sites of the IL-2 gene
promoter (NFAT (IL2)). In contrast to Nck2- knock-
down cells, Nck1-knockdown cells showed significantly
decreased TCR-induced AP-1-dependent luciferase ex-
pression (Figure 4C) as compared to control cells. How-
ever, TCR-induced NFAT (IL2) activation was statistically
Figure 3 Nck1 is required for TCR-induced CD69 expression in primary cells. Peripheral blood mononuclear cells (PBMC) were isolated from
buffy coat derived from healthy blood donors. Cells were treated with siRNA specific to either Nck1 or Nck2 and treated with both siRNA specific to
Nck1 and Nck2. A) The expression of Nck was analysed by immunoblotting. B) The expression levels of surface CD3 molecules on these knockdown
primary cells were measured by flow cytometry. C-D) siRNA-treated cells were stimulated either with anti-CD3 antibody or PHA/PMA for 24 hr. Cells
were then harvested and stained with PerCP-conjugated mouse anti-human CD4 mAb and PE-conjugated mouse anti-human CD69 antibody before
analysing by flow cytometry. Numbers in CD69 histogram indicate frequency of positive cells within a CD4 gated population. Grey shaded histrogram
and grey letter are cells treated with control siRNA, black bold solid line and black letter are cells treated either with siRNA specific to Nck1 or Nck2,
and black dotted line is isotype control staining.
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compared with control cells (Figure 4D). Although Nck2-
knockdown cells had a defective NFAT activation whencompared to control cells, they retained the ability to
maintain TCR-mediated IL-2 production to normal levels
(Figure 2C). These results, at least in part, suggest that
Figure 4 Dispensable role of Nck protein in TCR-induced Ca2+ mobilization. A) Cells were loaded with Indo-1 AM and baseline was measured
for 1 min before stimulation with OKT3 antibody. The ratio of Ca2+-bound and -unbound forms of Indo-1 AM was monitored by flow cytometry. Data
are representative from three independent experiments. B) Cells were stimulated with soluble anti-CD3 antibody (1 μg/ml) at various time points.
Lysates were immunoblotted with anti-phospho-IκBα (Ser32) antibody. Below, signal intensity was quantified and presented as a ratio of p-IκBα to
GAPDH relative to that in unstimulated control cells (Mock), set as 1 (black dashed line). Data are representative of two independent experiments.
C) Cells were transiently co-transfected with pAP-1-Luc and control pGL4.7 plasmid. After 20 hr of transfection, cells were left untreated or stimulated
with plate-bound monoclonal antibody to CD3, or with a combination of PMA and ionomycin. Cells were then lysed and measured for the luciferase
activity. To control for the transfection efficiency, the pAP-1-Luc activity was normalized to the Renilla luciferase activity. Bars represent the mean
luciferase activities ± SD from triplicate wells and expressed as percentage of the response to PMA plus ionomycin (PI) and are representative of two
independent experiments. D) Each cell population was transiently co-transfected with the pNFAT(IL2)-Luc reporter plasmid plus control pGL4.7
plasmid. After 20 hr of transfection, cells were carried out as described above. Bars represent the mean luciferase activities ± SD and expressed as
percentage of the response to PMA plus ionomycin (PI). The results were compared among the groups by using the two-tailed unpaired t test.
The p-value less than 0.05 were considered for statistical significance. The data are representative of two independent experiments.
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their simultaneous impairments eventually abrogated IL-2
production.
The C-terminal SH3 domain of Nck1 controls activation of
the Erk1/2 pathway and CD69 expression
In human myelogenous leukemia cell line, the C-terminal
SH3 (SH3.3) domain of Nck has been documented to bind
to SOS, a guanine nucleotide exchange factor for Ras. It
was also suggested that other SH3 domains of Nck1 might
be implicated in high affinity binding to SOS [14]. An
interaction of Nck to SOS implies that Nck is involved inRas activation, which stimulates various downstream sig-
nalling proteins including Erk1/2. In this present study,
we performed point mutation at either SH3.1 or SH3.3
domain of Nck1 by changing the tryptophan residue at
position 38 or 229 within the conserved WW motifs to ly-
sine corresponding to SH3.1 and SH3.3, respectively [19]
(Figure 5A). This residue has been reported as the essen-
tial site for binding to its partner without affecting the
binding activity of the unmutated domains [20]. The pro-
tein expression of reconstituted plasmids encoding wild
type (WT) Nck1 and Nck1 mutants tagged with Flag was
monitored by immunoblotting (Figure 5B).
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Figure 5 (See legend on next page.)
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Figure 5 The C-terminal SH3 domain of Nck1 is necessary for an efficient Erk1/2 activation. A) Schematic presentation of Nck1 SH3.1 and
SH3.3 mutant constructs. A nucleotide fragment encoding the FLAG peptide was linked in frame to the N-terminal of the Nck1 gene. N-terminal SH3
(SH3.1) and C-terminal SH3 (SH3.3) domains of Nck1 were mutated by changing tryptophan (W) residue at 38 and 229 to lysine (K), respectively. B) The
reconstitution of WT Nck1, Nck1 W38K and Nck1 W229K in Nck1-knockdown cells were analyzed by immunoblotting with anti-Nck1 antibody.
C-D) Nck1-knockdown cells stably expressing WT Nck1, Nck1 W38K and Nck1 W229K mutants were stimulated with plate pre-coated with 1 μg/ml
anti-CD3 antibodies or 6 μg/ml PHA plus 1 ng/ml PMA for 24 h. Each cell population was stained with anti-CD69 conjugated phycoerythrin (PE) and
isotype control antibody and then analysed by flow cytometry. Numbers in CD69 histogram indicate frequency of positive cells. Grey shaded
histrogram and grey letter are cells transfected with empty plasmid (Mock), black bold solid line and black letter are Nck1-knockdown cells or
Nck1-knockdown cells reconstituted with indicated construct plasmids, and black dotted line is isotype control staining. Data are representative of two
independent experiments. E) Nck1-knockdown cells reconstituted as describe in C were left untreated or treated with soluble CD3 antibody (1 μg/ml)
for 3 min. Lysates were immunoblotted with anti-phospho-Erk1/2 (Thr202/Tyr204, Thr185/Tyr187) antibody and anti-Erk1/2 antibody. Below, the
quantified signal intensity of the pErk1/2 was normalized to its total kinase and this value was relative to that in the unstimulated control cells (Mock),
set as 1 (black dashed line) and plotted in bar graph. Data are representative of two independent experiments.
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lation was specifically restored in Nck1-knockdown cells
reconstituted with WT Nck1 and Nck1 W38K, but not
with Nck1 W229K (Figure 5C). Importantly, the reconsti-
tution of Nck1 W229K domain to Nck1-knockdown cells
caused CD69 upregulation in response to TCR-indepen-
dent stimulation (PHA/PMA) equivalent to that in cells
reconstituted WT Nck1 and Nck1 W38K (Figure 5D).
Furthermore, in contrast to mutation at Nck1 SH3.1,
mutation at Nck1 SH3.3 domain did not restore TCR-
induced Erk1/2 phosphorylation (Figure 5E). Altogether,
the SH3.3 domain of Nck1 plays an important role in
regulation of TCR-mediated T cell activation.
Discussion
Our previous report has shown that Nck1 is required for
Jurkat T cell activation [17]. In the present study, we
characterize the roles of Nck1 and Nck2 in human T cell
activation using Jurkat T cells as a model and CD4+ pri-
mary T cells. Our results show that knockdown of Nck1,
but not Nck2, caused an impaired IL-2 production and
CD69 expression. These impairments were accompanied
by the reduction of Erk1/2 and MEK1/2 phosphory-
lation, which were observed in Nck1-knockdown T cells,
but not in Nck2-knockdown T cells. In contrast to
MEK-Erk activation, neither downregulation of Nck1
nor Nck2 had any discernible effects on p38 phosphory-
lation. Although Erk1/2 and p38 are MAPK family
members, their activation differentially relies on Ras and
Rac, respectively [3,21]. Notably, Ras activation is con-
trolled by SOS [15] and it has been found that Nck can
interact with SOS [10,14]. This interaction is mediated
predominantly by SH3.3 domain of Nck and proline-rich
region of SOS. Although the single SH3.3 domain of
Nck mediates this interaction, the high affinity binding
of Nck to SOS requires other SH3 domains of Nck.
Since the activation of Ras is essential for Erk1/2 activa-
tion, CD69 expression and IL-2 gene transcription [22],
we performed a point mutation in the SH3.1 (Nck1W38K) and SH3.3 (Nck1 W229K) domains of Nck1.
These mutated genes were then expressed in Jurkat cells
in which Nck1 was previously silenced. In contrast to
Nck1 W38K, our results clearly show that the Nck1
W229K did not restore the function of full length Nck1
in respect to CD69 upregulation or Erk1/2 phosphory-
lation upon TCR triggering. Thus, we highlighted the
important roles of the SH3.3 domain of Nck1 in linking
TCR triggering and Ras-ERK pathway activation in
Jurkat T cells.
The cooperative binding of AP-1 and NFAT to pro-
moter/enhancer regions of IL-2 gene is absolutely re-
quired to elicit IL-2 transcription [23,24]. Using luciferase
reporter assays, we have detected a specific reduction of
AP1-mediated transcription in Jurkat cells in which Nck1
was silenced. In contrast, Nck2-silenced cells show tran-
scription levels comparable to control Jurkat cells. The
reduction in AP1-mediated transcription in Nck1-knock-
down cells is probably related to the reduction in TCR-
induced Erk phosphorylation, whereas these events were
normal in Nck2-knockdown cells. Reduced AP1-tran-
scriptional activity as consequence of impaired Erk activa-
tion has been previously reported [25,26].
Interestingly, although the TCR-triggered Ca2+ influx
was not altered in Nck1- and Nck2-knockdown T cells,
these cells failed to induce downstream NFAT (IL2)-
dependent transcriptional responses. One possible ex-
planation is that both Nck isoforms are involved in the
transduction of the activation signal downstream of Ca2+
influx. Another possibility might be that there is an alter-
native pathway, apart from Ca2+ signalling, that links TCR
triggering to NFAT activation. Consistent with this hy-
pothesis, it has been reported that following TCR stimula-
tion, Pak1 is activated and associates with the SH3.2
domain of Nck [12]. Pak1 can be activated independent of
Ras activation or calcium flux and this occurs downstream
of Vav and Cdc42. The association of Nck-Pak1 is essen-
tial for TCR-mediated activation of NFAT transcription
factor, since inhibition of NFAT transcriptional activity
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mutated such that it failed to bind to Pak1. Although the
mechanisms by which both Nck isoforms play non-
redundant role in TCR-induced NFAT activation are not
known, AP-1 activity was not reduced and NFAT activity
was less reduced in Nck2-knockdown cells as compared
with Nck1-knockdown cells. Therefore it might be that to-
gether the transcription was over the threshold needed to
exhibit normal IL-2 production.
Reduction of NFAT in Nck2-knockdown cells did not
affect the levels of IL-2 production. AP-1 activation was
unaltered in Nck2-knockdown cells. It is possible, that
low amounts of active NFAT may be sufficient to form a
complex with normal amounts of AP-1 to induce IL-2
production. In contrast, in Nck1-knockdown cells AP-1
and NFAT activities are reduced such that they cannot
optimally promote IL-2 transcription. Indeed, it has been
previously shown that NFAT activation in the absence of
AP-1 activation substantially decreases the IL-2 produc-
tion [24].
Nck1 and Nck2 protein sequences share only 68%
amino acid identity both in humans and mice. However,
mouse Nck1 is compared with human Nck1 and mouse
Nck2 with human Nck2, the amino acid identity is over
95% [27]. Mice with single knock-out of Nck1 or Nck2
do not have any apparent phenotype whereas double
knock-out mice die in the early embryonic stage. Thus, a
functional redundancy between these Nck isoforms in
mice was proposed [16]. Although, there are evidences
that Nck1 and Nck2 share a redundant role in TCR-
induced actin polymerization in Jurkat T cells [28], this
present report identified the non-overlapping function of
Nck1 and Nck2 in TCR signalling and activation in the
human system. Thus, it seems that Nck1 and Nck2 have
redundant roles in the mice system but not in the
human system. One explanation could be the 5% of
non-identical sequence or species-specific interacting
partners. However, an alternative explanation could be
that in the knock-out mice the cells have evolved with
only one of the Nck isoforms, and thus they have
adapted their signalling pathways to efficiently function
under these conditions. In contrast, our approach leads
to an abrupt decrease in the expression of one of the
isoforms, the plasticity of the mature cell is thus not
enough to adapt to the new conditions.
Conclusions
In conclusion, our results demonstrate that two closely re-
lated adaptor proteins Nck1 and Nck2 are functionally
non-redundant in TCR-mediated T cell activation. Nck1
plays a major role than Nck2 when controlling TCR-
induced transcription and protein expression. In addition,
the third SH3 domain of Nck1 is critical for TCR-
mediated T cell activation.Methods
Antibodies
Mouse anti-CD3 (OKT-3) antibody was purchased
from e-Bioscience (eBioscience, San Diego, CA, USA).
Anti-Nck1, anti-phospho-MEK1/2 and anti-phospho-p38,
antibodies were from Cell Signaling (Cell Signaling Tech-
nology, Danver, MA, USA). Anti-Nck2 antibody was pur-
chased from Abnova (Abnova Corp., Taipei, Taiwan).
Anti-phospho-Erk1/2 antibody was from Upstate (Upstate
Biotechnology, Lake Placid, NY, USA). Anti-phospho IκBα
antibody was supplied from Santa Cruz (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). FITC-conjugated
anti-CD3 and PE-conjugated anti-CD69 antibodies were
purchased from eBioscience (eBioscience, San Diego, CA,
USA).
Construction of Nck1- and Nck2- specific shRNA and
transfection
The Nck1- and Nck2-specific RNA interference (RNAi) se-
quences that were used to generate Nck1 and Nck2 shRNA
have been described previously [17,28]. Upper and lower
strand of shRNA oligonucleotides specific to each Nck
isoform were purchased from Invitrogen (Invitrogen,
Carlsbad, CA, USA). The sequence of 5′- to 3′-end oligo-
nucleotides were GATCCGGGGTTCTCTGTCAGAGA
AATTCAAGAGA TTTCTCTGACAGAGAA CCCTTTT
TTACGCGTG for shNck1 upper strand, AAT TCA
CGCGTAAAAAAGGGTTCTCTGTCAGAGAAATCTCT
TGAATTTCTCTG ACAGAGAACCCCG for shNck1
lower strand, GATCC GCTTAAAGCGTCAGGG AAGA
TTCAAGAGATC TTCCC TGACGCTTTAAGTTTTT
TACGCGTG for shNck2 upper strand, and AATTCA
CGCGTAAAAAACTTAAAGCGTCAGGGAA GATCTC
TTGAATCTTCCC TGACGCTTTAAGCG for shNck2
lower strand. Each counterpart oligonucleotides were an-
nealed and then inserted into pLVX-shRNA1 vector at
BamHI and EcoRI sites (Takara Shuzo, Tokyo, Japan). The
resulting vectors were verified by DNA sequencing before
transfection into Jurkat T cells.
Cell culture and transfection
In order to knockdown either Nck1 or Nck2 protein in
Jurkat T cells, cells were cultured and transfected as
previously described [17]. Briefly, 2.0 × 105 cells were
transfected either with 0.5 μg of pLVX-shNck1 or
pLVX-shNck2 or both plasmids. Transfected cells were
then incubated at 37°C in a humidified CO2 incubator
for 48 hr. Stable Nck1- and Nck2-knockdown Jurkat T
cell lines were obtained by culturing transfected cells in
medium containing 1.0 μg/ml puromycin for 4–7 days.
Then, the Jurkat T cell clones were obtained from these
lines by limiting dilution technique. Clones that pro-
vided a similar level of TCR surface expression as evalu-
ated by flow cytometry were selected for further studies.
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lated from buffy coats obtained from normal blood donors
at the Blood Bank Center of Naresuan University Hospital.
The used of buffy coats was approved by the ethical
committee of Naresuan University. The PBMCs were
transfected as previously described [17]. Human Nck1 and
Nck2 small interfering RNA (siRNA) oligonucleotides
were purchased from Invitrogen. The transfected PBMCs
were subsequently cultured in RPMI-1640 plus FBS for
48 h before performing functional study.
Flow cytometry
The expression of CD3 molecules on T cell surface were
determined using anti-CD3 conjugated FITC antibody. To
determine the expression of CD69, Jurkat and primary
cells were stimulated as previously described [17] and
stimulated cells were stained with anti-CD69 conjugated
phycoerythrin (PE) antibody. Stained cells were analyzed
on a FACSCalibur (Becton Dickinson, NJ, USA) and data
were analyzed with CellQuestPro software.
Analysis of IL-2 production
The measurement of IL-2 production was performed as
previously described [17]. Briefly, cells at 1 × 106 cells/ml
were incubated in micro titer plates that were pre-coated
with 1 μg/ml of anti-CD3ε monoclonal antibody (mAb) or
with 6 μg/ml of phytohaemagglutinin (PHA) and 1 ng/ml
of phorbolmyristate acetate (PMA) for 24 hours at 37°C.
The supernatants were collected and stored at −80°C until
assayed. IL-2 levels were determined using a commercial
enzyme-linked immunosorbent assay (ELISA) kit (R&D,
Minneapolis, MN, USA) following the manufacturer’s in-
structions. The optical density at 450 nm was read using a
microplate reader (Perkin Elmer, MA, USA).
Western blotting analysis
A total of 5×106 cells was resuspended in serum-free
RPMI medium and incubated in an incubator for 60 min.
Cells were left untreated or treated with anti-CD3 (OKT3)
antibody at different times points. After incubation at each
time point, cells were lysed in Brij96 lysis buffer con-
taining protease and phosphatase inhibitors (20 mM
Tris–HCl (pH 8.0), 137 mM NaCl, 2 mM ethylenediamine
tetraacetic acid (EDTA), 10% glycerol, 10 mg/ml leupep-
tin, 10 mg/ml aprotinin, 1 mM phenylmethylsulphonyl
fluoride (PMSF), 500 mM sodium orthovanadate, 1 mM
sodium fluoride (NaF) and 0.5% Brij96). The samples were
left on ice for 15 min and then centrifuged at 12,000 rpm
for 15 min. The supernatants were collected and 25 μg of
total protein were loaded in each lane of SDS-PAGE and
western blotting analysis according to standard proce-
dures. The membranes were probed with anti-phospho-
specific antibodies and observed under a CCD camera
(ImageQuant LAS 4000; GE Healthcare Life Sciences,Pittsburgh, PA, USA). Relative band intensity was quanti-
fied by ImageJ software and shown as the mean ± SE.
Ca2+ influx measurement
Five million cells were resuspended in 1 ml RPMI sup-
plemented with 1% fetal calf serum (FCS) and incubated
with calcium indicator Indo-1 AM (2 μM; Molecular
Probes, Invitrogen) for 45 min at 37°C in 5% CO2 with
gentle vortexing every 15 min. Cells were washed twice
and finally resuspended with 2 ml RPMI supplemented
with 1% FCS. Cells were pre-warmed to 37°C before
analysis and were maintained at 37°C during event collec-
tion on a Becton Dickinson (BD) LSR II Flow Cytometer
(Beckton Dickinson). Baseline fluorescence was monitored
for 1 min. After 1 min data acquisition began, anti-CD3
antibody (OKT3) at a final concentration of 1 μg/ml was
added and the stimulation was induced for 5 min. Kinetic
analysis was performed with FlowJo kinetics platform
(FlowJo v8.8.4 software (Tree Star)) and data were pre-
sented as the ratio of Ca2+-bound and unbound Indo-1.
Luciferase assay
The transfection procedure to introduce the luciferase
reporter plasmid into the cells was performed. 2×105
cells were transiently co-transfected with 0.45 μg of a
firefly luciferase reporter plasmid containing either AP-1
(pAP-1-Luc) or NF-AT binding sites (pGL3 NFAT-Luc)
and 0.05 μg pGL4.7 control plasmid (Renilla luciferase
plasmid). After 16–20 hr, cells were harvested and 1×105
cells were cultured at 37°C for 6 h in complete medium
alone (unstimulated), or stimulated either with plate-
bound anti-CD3 mAb, or with 50 ng/ml phorbol 12-
myristate 13-acetate (PMA) and 1 mM ionomycin. After
stimulation period, cells were lysed and assayed for luci-
ferase activity according to the manufacturer’s instruc-
tions. To correct the variations in transfection efficiency,
the values of NFAT luciferase activity were normalized
with the activity of the Renilla luciferase.
Generation of Nck1 mutant and transfection
All mutants were generated by site-directed mutagenesis of
double-stranded DNA using QuickChange® Lightning Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA). Human
FLAG-tagged Nck-1 cDNA containing in pEBB plasmid
was kindly provided by Prof. Bruce Mayer, the Connecticut
University Health Center, Farmington, CT, USA. Nck1 wild
type (WT) was rendered resistant to Nck1 shRNA by site-
directed mutagenesis with primers indicated below. The
Nck1 mutant was done on the SH3 domain by changing
the first tryptophan (W) residue in the conserved WW
motif to lysine (K) [19]. The primers for doing these
mutations were: Nck1 resistance forward 5′-GTGAC
CATGTGGGTTCCCTCTCCGAGAAATTAGC AGC-3′,
Nck1 resistance reverse 5′-GCTGCTAATTTCTCGGA
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ward 5′-GCTTCTGGATGATTCTAAGTCCAA GTGGC
GAGTTCGAAATTCC-3′ and Nck1 (W38K) reverse 5′-
GGAATTTCGAAC TCGCCACTTGGACTTAGAATCAT
CCAGAAG C-3′, Nck1 (W229K) forward 5′-CCTGA
AAATGA CCCAGAGAAGTGGAAATGCAGGAAGATC
AATGG-3′and Nck1 (W229K) reverse 5′-CCATTGAT
CTTCCTGCATTTCCACTTCTCTGGGT CATTTTCA
GG-3′.
PCR reactions and conditions were performed ac-
cording to manufacturer’s instruction (Stratagene). The
resulting DNA was then confirmed by DNA sequencing
analysis. To generate Nck1-knockdown Jurkat cells stably
expressing wild type Nck1, or the Nck1 mutant, a total of
2 × 105 cells were co-transfected with pEBB plasmid con-
taining either WT Nck1, Nck1 W38K, or Nck1 W229K
(0.4 μg DNA) and pDsRed-Monomer-Hyg-N1 (0.1 μg
DNA) (Clonetech, Mountain View, CA, USA), which
provides resistance to the antibiotic hygromycin. Fourty-
eight hours following transfection, transfected cells were
selected for 3–5 days in media containing 400 μg/ml
hygromycin. Selected cells were screened for Nck1 re-
expression by immunoblotting.
Statistical analysis
Statistical analyses were performed using SPSS software.
All differences between experimental groups were ana-
lysed with student’s t-test. The differences were consi-
dered to be significant when P <0 · 05.
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